• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

It takes two to bleed: anticoagulation intensity and the host's vascular susceptibility. Author's reply.

作者信息

Nunez Jose I, Grandin E Wilson

机构信息

Department of Internal Medicine, Montefiore Medical Center, Albert Einstein Medical College, New York, USA.

Advanced Heart Failure and Transplant Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.

出版信息

Intensive Care Med. 2022 May;48(5):621-623. doi: 10.1007/s00134-022-06636-x. Epub 2022 Mar 14.

DOI:10.1007/s00134-022-06636-x
PMID:35284944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8918361/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/8918361/c2fde00cac43/134_2022_6636_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/8918361/c2fde00cac43/134_2022_6636_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/866b/8918361/c2fde00cac43/134_2022_6636_Fig1_HTML.jpg

相似文献

1
It takes two to bleed: anticoagulation intensity and the host's vascular susceptibility. Author's reply.出血涉及两个因素：抗凝强度和宿主血管易感性。作者回复。
Intensive Care Med. 2022 May;48(5):621-623. doi: 10.1007/s00134-022-06636-x. Epub 2022 Mar 14.
2
It takes two to bleed: anticoagulation intensity and the host's vascular susceptibility.出血涉及两个因素：抗凝强度和宿主血管易感性。
Intensive Care Med. 2022 May;48(5):619-620. doi: 10.1007/s00134-022-06643-y. Epub 2022 Feb 10.
3
[Mediastinal hemorrhage complicating combined streptokinase-anticoagulant therapy (author's transl)].链激酶-抗凝联合治疗并发纵隔出血（作者译）
Rontgenblatter. 1975 Aug;28(8):380-4.
4
Reversing the action of newer oral anticoagulants--author's reply.新型口服抗凝药作用的逆转——作者回复
Am J Health Syst Pharm. 2013 Jan 1;70(1):16-7. doi: 10.2146/ajhp120617.
5
Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous-flow left ventricular assist devices.连续流左心室辅助装置接受者的抗凝与非手术性大出血评估
Artif Organs. 2019 Aug;43(8):736-744. doi: 10.1111/aor.13456. Epub 2019 Apr 24.
6
A complicated case of anticoagulation.一例复杂的抗凝病例。
BMJ Case Rep. 2013 Jan 9;2013:bcr2012007672. doi: 10.1136/bcr-2012-007672.
7
Oral anticoagulation thresholds.口服抗凝阈值。
Circulation. 2001 Nov 6;104(19):2311-7. doi: 10.1161/hc4401.098492.
8
[Drug-induced disturbances of the coagulation system (author's transl)].药物引起的凝血系统紊乱（作者译）
MMW Munch Med Wochenschr. 1980 Aug 29;122(35):1184-90.
9
Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation.直接口服抗凝剂与华法林在慢性肝病合并心房颤动患者中的安全性比较。
Eur J Haematol. 2018 May;100(5):488-493. doi: 10.1111/ejh.13045. Epub 2018 Mar 13.
10
[Abnormalities of blood coagulation and fibrinolysis in acute leukemia--their influence on bleeding tendency (author's transl)].急性白血病时血液凝固与纤维蛋白溶解的异常——它们对出血倾向的影响（作者译）
Nihon Ketsueki Gakkai Zasshi. 1975 Apr;38(2):143-56.

引用本文的文献

1
Lactate Dehydrogenase and Hemorrhagic Stroke During Extracorporeal Membrane Oxygenation for COVID-19.COVID-19 患者体外膜肺氧合治疗期间的乳酸脱氢酶和出血性卒中。
Lung. 2023 Aug;201(4):397-406. doi: 10.1007/s00408-023-00630-w. Epub 2023 Jul 4.

本文引用的文献

1
It takes two to bleed: anticoagulation intensity and the host's vascular susceptibility.出血涉及两个因素：抗凝强度和宿主血管易感性。
Intensive Care Med. 2022 May;48(5):619-620. doi: 10.1007/s00134-022-06643-y. Epub 2022 Feb 10.
2
Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis.体外膜肺氧合支持成人的出血和血栓事件：ELSO 登记分析。
Intensive Care Med. 2022 Feb;48(2):213-224. doi: 10.1007/s00134-021-06593-x. Epub 2021 Dec 18.
3
Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure.
比较急性呼吸衰竭患者静脉-静脉体外膜肺氧合支持的抗凝策略。
Crit Care. 2021 Jan 4;24(1):701. doi: 10.1186/s13054-020-03348-w.